Skip to main content

Table 4 Comparison of clinical parameters between groups

From: Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARBs) may be safe for COVID-19 patients

Parameters At admission At discharge statistical value p
Group A: ALT (U/L) 35.05 ± 19.17 32.50 ± 24.72 1.571 0.116
Group B: ALT (U/L) 34.75 ± 22.93 31.13 ± 17.62 −1.220 0.222
statistical value −0.454a −0.220a
P 0.650 0.826
Group A: Cr (μmol/L) 68.50 ± 14.53 67.14 ± 1 −0.114 0.909
Group B: Cr (μmol/L) 75.26 ± 20.54 72.00 ± 13.63 −0.488 0.626
statistical value −0.189a −1.130a
P 0.276 0.183
Group A: CK (U/L) 49.68 ± 25.61 49.95 ± 15.35 −0.406 0.685
Group B: CK (U/L) 56.98 ± 32.40 55.51 ± 19.03 −0.887 0.375
statistical value −0.361a −1.030a
P 0.718 0.303
Group A:Hospitalization time (days) 27.41 ± 6.43
Group B:Hospitalization time (days) 30.07 ± 8.92
statistical value 1.246b
P 0.217
  1. a Wilcoxon rank-sum test. b Student’s t test